36 reports

  • 7. Global Cystic Fibrosis Pipeline Product Analysis - By Company & Phase of Development
  • 10.Global Cystic Fibrosis Market - Growth Drivers

Novartis Pharmaceuticals Corporation Novartis Pharmaceuticals Corporation Savara Pharmaceuticals CURx Pharma Anti-Inflammatory Anti-Infective Gallium (IV) ##.

  • Cystic Fibrosis
  • Pathology
  • Pharmaceutical
  • Therapy
  • Genzyme Corporation

Its enlisted among one of the world' s largest pharmaceutical companies.

  • Gene Therapy
  • Pharmaceutical
  • Therapy
  • Boehringer Ingelheim GmbH
  • Genzyme Corporation

Current Pharmaceutical Design; ##(##):##-##.

  • Artificial Intelligence
  • Healthcare
  • Information Technology
  • Pharmaceutical
  • Genzyme Corporation
  • Cystic Fibrosis Foundation Therapeutics Inc
  • GENETIC DISORDERS MARKET THERAPEUTICS MARKET, GLOBAL, CO-DEVELOPMENT DEALS, 2006-2017

Indian Journal of Pediatrics; ##(##): ##-## GW Pharmaceuticals (2017).

  • Clinical Trial
  • Genetic Disorder
  • Pharmaceutical
  • Therapy
  • Genzyme Corporation
  • MARKET PARTICIPANTS
  • COMPETITIVE SCENARIO

One such trend is the advent of modern technologies.

  • Pharmaceutical
  • United States
  • World
  • Forecast
  • Genzyme Corporation
  • Sanofi
  • Increase in R&D

You can easily book an appointment with one online.

  • Pharmaceutical
  • Therapy
  • Vaccine
  • Amgen Inc.
  • Genzyme Corporation

TEMCELL (JCR PHARMACEUTICALS CO.

  • Cell Therapy
  • Pharmaceutical
  • Therapy
  • Genzyme Corporation
  • Mesoblast Limited

ONE UNIT REFERS TO ONE SPECIALTY BED.

  • Hospital
  • Medical Supply
  • Pharmaceutical
  • Wound Care
  • Genzyme Corporation

ONE UNIT REFERS TO ONE SPECIALTY BED.

  • Hospital
  • Oxygen Device
  • Pharmaceutical
  • Wound Care
  • Genzyme Corporation
  • ALNYLAM PHARMA ENTERS INTO AGREEMENT WITH SANOFI GENZYME
  • RECURSION PHARMA ENTERS INTO RESEARCH AGREEMENT WITH GENZYME

Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis.It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosis I, multiple sclerosis,...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Genzyme Corporation
  • Market challenges

The incidence of adult-onset Pompe disease is one in ##, ## in Dutch adults followed by one in ##, ## in the Australian population.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Market Size
  • Genzyme Corporation
  • 18.2 BIOMARIN PHARMACEUTICAL
  • 17.2 MARKET SHARE ANALYSIS 2014

About Pompe Disease Pompe disease is a type of LSD. LSD refers to a group of diseases arising from the accumulation of specific substrates. LSDs are progressive and have variable age of onset and clinical symptoms. LSDs are inherited autosomal recessive disorders. Pompe disease has two broad sub-types: infantile-onset Pompe disease and...

  • Pharmaceutical
  • United States
  • World
  • Forecast
  • Genzyme Corporation

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • Vendor landscape
  • Scope of the report

You can easily book an appointment with one online.

  • Pharmaceutical
  • United States
  • Forecast
  • Market Size
  • Genzyme Corporation
  • SANOFI'S MULTIPLE SCLEROSIS PORTFOLIO ASSESSMENT, 2015

Journal of Neuroimmunology; ##(##): ##-##.

  • Pharmaceutical
  • Therapy
  • Biogen Idec Inc.
  • Genzyme Corporation
  • Novartis AG
  • 03.2 Product Offerings
  • 01. Executive Summary

Drivers and their Impact Special Orphan Drugs Provisions for Low ## ## ## ## ## High Low Pharmaceutical Stores High ## ## ## ## ## Hospitals Impact on Key End-User Category Driver Designated ICD-## Code Low Advertising Costs Driver Special Orphan Drugs Provisions for Low ##

  • Pathology
  • Pharmaceutical
  • World
  • Forecast
  • Genzyme Corporation
  • GLOBAL SALES OF BRANDED PRODUCTS FOR DYSLIPIDEMIA BY COMPANY, 2013-2023
  • KEY COMPANIES IN THE DYSLIPIDEMIA MARKET IN THE 8MM, 2014

S##. and Rehabilitation; ##(##): ##-##.

  • Cholesterol
  • Lipid Modifying Drug
  • Pharmaceutical
  • Therapy
  • Genzyme Corporation
  • Replagal SWOT Analysis, 2015
  • Fabrazyme SWOT Analysis, 2015

Pharma Japan Web (2015).

  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • Amicus Therapeutics
  • Genzyme Corporation
  • GAUCHER DISEASE: KEY METRICS IN THE SEVEN MAJOR PHARMACEUTICAL MARKETS, 2014-2024
  • Executive Summary

Opportunity Analyzer: Gaucher Disease - Opportunity Analysis and Forecast to 2024 Summary GlobalData estimated the 2014 sales for the Gaucher Disease (GD) market at approximately $875m across the 7MM (US, France, Germany, Italy, Spain, UK, and Israel). The US market contributed the majority of these sales, generating...

  • Pathology
  • Pharmaceutical
  • Israel
  • United States
  • Genzyme Corporation

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Genzyme Corporation
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Genzyme Corporation
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Genzyme Corporation
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Genzyme Corporation
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Genzyme Corporation
  • Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • GENZYME CORP, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2012 TO YTD 2018

Genzyme Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report...

  • Pharmaceutical
  • United States
  • Company
  • M&A
  • Genzyme Corporation
  • JCR Pharmaceuticals Co Ltd
  • Genzyme Corp

Gaucher Disease - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Pipeline Review, H1 2018, provides an overview of the Gaucher Disease (Genetic Disorders) pipeline landscape. Gaucher disease is a rare genetic...

  • Neurological Disorder
  • Pathology
  • Pharmaceutical
  • Therapy
  • Genzyme Corporation
  • JCR PHARMACEUTICALS CO LTD
  • GAUCHER DISEASE - PIPELINE BY GENZYME CORP, H2 2017

Gaucher Disease - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Pipeline Review, H2 2017, provides an overview of the Gaucher Disease (Genetic Disorders) pipeline landscape. Gaucher disease is a rare genetic...

  • Enzyme
  • Pathology
  • Pharmaceutical
  • Therapy
  • Genzyme Corporation